Edwards Lifesciences Corporation (VIE:EWLS)
71.58
-0.13 (-0.18%)
At close: Jan 13, 2026
Edwards Lifesciences Market Cap
Edwards Lifesciences has a market cap or net worth of €41.38 billion as of January 15, 2026. Its market cap has decreased by -3.28% in one year.
Market Cap
41.38B
Enterprise Value
38.68B
Revenue
5.01B
Ranking
n/a
PE Ratio
35.49
Stock Price
€71.58
Market Cap Chart
Since March 27, 2000, Edwards Lifesciences's market cap has increased from 984.05M to 41.38B, an increase of 4,105.08%. That is a compound annual growth rate of 15.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 41.38B | -1.79% |
| Dec 31, 2025 | 42.13B | -0.09% |
| Dec 31, 2024 | 42.17B | 0.80% |
| Dec 29, 2023 | 41.84B | -3.07% |
| Dec 30, 2022 | 43.16B | -39.31% |
| Dec 31, 2021 | 71.12B | 53.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erste Group Bank AG | 40.39B |
| VERBUND AG | 21.99B |
| OMV Aktiengesellschaft | 16.08B |
| Raiffeisen Bank International AG | 12.60B |
| BAWAG Group AG | 10.06B |
| Strabag SE | 9.52B |
| Vienna Insurance Group AG | 8.60B |
| Voestalpine AG | 6.86B |